Skip to content

The treatment of chronic insomnia by using Bioboosti: A randomized blind, placebo-controlled, two-center clinical trial

Safety and efficacy of Bioboosti in the treatment of chronic insomnia: A randomized blind, placebo-controlled, two-center clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021985
Enrollment
Unknown
Registered
2019-03-19
Start date
2019-03-29
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Insomnia

Interventions

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients with chronic insomnia were diagnosed according to ICSD-3 criteria; 2. Aged 21-60 years; 3. The patient himself can understand the procedure and method of the trial, voluntarily and strictly abide by the clinical trial program to complete the trial, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Population with the following conditions: pregnant women; patients with severe sleep apnea, sleep rhythm disorders, severe cardiovascular and cerebrovascular diseases, acute and chronic lung diseases, neurodegenerative diseases (such as Parkinson's disease, dementia, etc.) or epilepsy; patients who are using various stimulator devices, such as cardiac pacemaker, brain depth stimulator, thalamic stimulator, vagus nerve stimulator Transcranial magnetic stimulator, etc.; 2. Benzodiazepines or physiotherapy one month before admission; 3. Researchers believe that there are any other situations that may cause subjects to fail to complete the study or risk them.

Design outcomes

Primary

MeasureTime frame
PSQI;ISI;

Secondary

MeasureTime frame
ESS;BAI?BDI;

Countries

China

Contacts

Public ContactTang Xiangdong

West China Hospital of Sichuan University

2372564613@qq.com+86 18980602059

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026